KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Current Deferred Revenue: 2009-2012

Historic Current Deferred Revenue for Bausch Health Companies (BHC) over the last 3 years, with Dec 2012 value amounting to $7.0 million.

  • Bausch Health Companies' Current Deferred Revenue fell 44.99% to $7.0 million in Q4 2012 from the same period last year, while for Dec 2012 it was $7.0 million, marking a year-over-year decrease of 44.99%. This contributed to the annual value of $7.0 million for FY2012, which is 44.99% down from last year.
  • Bausch Health Companies' Current Deferred Revenue amounted to $7.0 million in Q4 2012, which was down 61.24% from $18.1 million recorded in Q3 2012.
  • In the past 5 years, Bausch Health Companies' Current Deferred Revenue registered a high of $23.3 million during Q3 2010, and its lowest value of $7.0 million during Q2 2012.
  • Moreover, its 3-year median value for Current Deferred Revenue was $18.1 million (2012), whereas its average is $16.0 million.
  • Examining YoY changes over the last 5 years, Bausch Health Companies' Current Deferred Revenue showed a top increase of 23.02% in 2012 and a maximum decrease of 63.12% in 2012.
  • Over the past 4 years, Bausch Health Companies' Current Deferred Revenue (Quarterly) stood at $21.8 million in 2009, then declined by 1.44% to $21.5 million in 2010, then slumped by 40.60% to $12.8 million in 2011, then slumped by 44.99% to $7.0 million in 2012.
  • Its last three reported values are $7.0 million in Q4 2012, $18.1 million for Q3 2012, and $7.0 million during Q2 2012.